Nakiboneka R - Search Results

1

Specific human gene expression in response to infection is an effective marker for diagnosis of latent and active tuberculosis.

Nakiboneka R, Walbaum N, Musisi E, Nevels M, Nyirenda T, Nliwasa M, Msefula CL, Sloan D, Sabiiti W. Nakiboneka R, et al. Sci Rep. 2024 Nov 6;14(1):26884. doi: 10.1038/s41598-024-77164-5. Sci Rep. 2024. PMID: 39505948 Free PMC article.

2

Suppression of host gene expression is associated with latent TB infection: a possible diagnostic biomarker.

Nakiboneka R, Margaritella N, Nyirenda T, Chaima D, Walbaum N, Musisi E, Tionge S, Msosa T, Nliwasa M, Msefula CL, Sloan D, Sabiiti W. Nakiboneka R, et al. Sci Rep. 2024 Jul 7;14(1):15621. doi: 10.1038/s41598-024-66486-z. Sci Rep. 2024. PMID: 38972907 Free PMC article.

3

The role and implications of RNAscope and mRNA in the diagnosis of tuberculosis.

Nakiboneka RF, Sabiiti W. Nakiboneka RF, et al. EBioMedicine. 2024 Jul;105:105230. doi: 10.1016/j.ebiom.2024.105230. Epub 2024 Jul 2. EBioMedicine. 2024. PMID: 38959847 Free PMC article. No abstract available.

4

Examining oral pre-exposure prophylaxis (PrEP) literacy among participants in an HIV vaccine trial preparedness cohort study.

Chimukuche RS, Kawuma R, Mahapa N, Mkhwanazi S, Singh N, Siva S, Ruzagira E, Seeley J; PrEPVacc Study Group. Chimukuche RS, et al. BMC Health Serv Res. 2022 Nov 10;22(1):1336. doi: 10.1186/s12913-022-08730-8. BMC Health Serv Res. 2022. PMID: 36357877 Free PMC article.

5

Interferon gamma (IFN-γ) negative CD4+ and CD8+ T-cells can produce immune mediators in response to viral antigens.

Nakiboneka R, Mugaba S, Auma BO, Kintu C, Lindan C, Nanteza MB, Kaleebu P, Serwanga J. Nakiboneka R, et al. Vaccine. 2019 Jan 3;37(1):113-122. doi: 10.1016/j.vaccine.2018.11.024. Epub 2018 Nov 17. Vaccine. 2019. PMID: 30459072 Free PMC article.

6

HIV-1 superinfection can occur in the presence of broadly neutralizing antibodies.

Serwanga J, Ssemwanga D, Muganga M, Nakiboneka R, Nakubulwa S, Kiwuwa-Muyingo S, Morris L, Redd AD, Quinn TC, Kaleebu P; HIV Superinfection Study Group. Serwanga J, et al. Among authors: nakiboneka r. Vaccine. 2018 Jan 25;36(4):578-586. doi: 10.1016/j.vaccine.2017.11.075. Epub 2017 Dec 20. Vaccine. 2018. PMID: 29274699

7

Frequencies of Gag-restricted T-cell escape "footprints" differ across HIV-1 clades A1 and D chronically infected Ugandans irrespective of host HLA B alleles.

Serwanga J, Nakiboneka R, Mugaba S, Magambo B, Ndembi N, Gotch F, Kaleebu P. Serwanga J, et al. Among authors: nakiboneka r. Vaccine. 2015 Mar 30;33(14):1664-72. doi: 10.1016/j.vaccine.2015.02.037. Epub 2015 Feb 26. Vaccine. 2015. PMID: 25728323 Free PMC article.

8

Group M consensus Gag and Nef peptides are as efficient at detecting clade A1 and D cross-subtype T-cell functions as subtype-specific consensus peptides.

Mugaba S, Nakiboneka R, Nanyonjo M, Bugembe-Lule D, Kaddu I, Nanteza B, Tweyongyere R, Kaleebu P, Serwanga J. Mugaba S, et al. Among authors: nakiboneka r. Vaccine. 2014 Jun 24;32(30):3787-95. doi: 10.1016/j.vaccine.2014.05.021. Epub 2014 May 14. Vaccine. 2014. PMID: 24837770 Free PMC article.

9

Quantitative and qualitative differences in the T cell response to HIV in uninfected Ugandans exposed or unexposed to HIV-infected partners.

Pala P, Serwanga J, Watera C, Ritchie AJ, Moodie Z, Wang M, Goonetilleke N, Birabwa E, Hughes P, Senkaali D, Nakiboneka R, Grosskurth H, Haynes B, McMichael A, Kaleebu P; Center for HIV/AIDS Vaccine Immunology. Pala P, et al. Among authors: nakiboneka r. J Virol. 2013 Aug;87(16):9053-63. doi: 10.1128/JVI.00721-13. Epub 2013 Jun 12. J Virol. 2013. PMID: 23760253 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9 results

Search Page

Filters